Curis Inc (CRIS) Dividend History

Curis Inc. (CRIS) is a biotechnology company focused on the development and commercialization of targeted cancer therapies. The company specializes in discovering and developing proprietary small molecule drugs that modulate the immune response and tumor growth pathways, aiming to advance innovative treatments for cancer patients.

128 Spring Street, Lexington, MA, 02421
Phone: 617-503-6500
Website:

Dividend History

Curis Inc currently does not pay dividends

Company News

  • VISTA inhibitors are an emerging class of immunotherapeutic agents with significant potential in treating cancer and autoimmune diseases. Several companies are actively pursuing VISTA inhibitors, which offer a novel mechanism of action and broad applicability, but also face challenges such as complex development landscape and competition from existing therapies.

    GlobeNewswire Inc.
    Featured Companies: MRK SNSE
  • As of April 12, 2024, three stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down. When compared to a stock's price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the RSI is above ...

    Benzinga
    Featured Companies: OCX RVMD
  • Curis (CRIS) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.

    Zacks Investment Research
    Featured Companies: MRSN
  • Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Telsey Advisory Group raised the price target for Ralph Lauren Corporation (NYSE: RL) from $165 to $195. Telsey Advisory Group analyst Dana Telsey maintained an Outperform rating. Ralph Lauren shares jumped 16.8% to close at $171.85 on Thursday. See how other analysts view this stock. HSBC cut Bunge Global SA (NYSE: BG) price target from $122 to $105. HSBC analyst Wesley Brooks upgraded the stock from Hold to Buy. Bunge Global shares fell 1.7% to close at $86.50 on Thursday. See how other analysts view this stock. Jefferies boosted the price target for Inotiv, Inc. (NASDAQ: NOTV) from $3 to $11.5. Jefferies analyst David Windley upgraded the stock from Hold to Buy. Inotiv shares gained 16.8% ...Full story available on Benzinga.com

    Benzinga
    Featured Companies: ALB BG CYBR EG LBTYA NOTV PCTY RL SPB
  • Shares of BlackBerry Limited (NYSE: BB) fell sharply during Wednesday’s session after the company announced a proposed private offering of $160 million of convertible senior notes. BlackBerry shares tumbled 17.2% to $2.9387 on Wednesday. Here are some other stocks moving in today's mid-day session. Gainers Getaround, Inc. (NYSE: GETR) shares jumped 151.3% to $0.4618 after the company announced a new debt facility with Mudrick Capital Management for up to $20 million. Evaxion Biotech A/S (NASDAQ: EVAX) gained 94.4% to $9.70 after a 13G filing showed Merck & Co reported an 11.4% stake in the company as of Dec. 21, 2023. SciSparc Ltd. (NASDAQ: SPRC) shares gained 61.3% to $5.58 after the company revealed $20 million standby equity purchase agreement. Kura Oncology, Inc. (NASDAQ: KURA) rose 41.3% to $18.99. Kura Oncology announced oversubscribed $150 million private placement. Ensysce Biosciences, Inc. (NASDAQ: ENSC) shares jumped 32.2% to $1.8372. Ensysce Biosciences shares gained 22% on Tuesday after the company announced FDA Breakthrough Therapy Designation for PF614-MPAR. RedHill Biopharma Ltd. (NASDAQ: RDHL) climbed 25.5% to $1.1197. Redhill Biopharma was granted U.S. Patent #11878011 for "Method for Eradicating Helicobacter Pylori Infection in Patients Regardless of Body Mass Index." Purple Innovation, Inc. (NASDAQ: PRPL) gained 24% to $1.02 after the company announced it strengthened its balance sheet, creating greater financial flexibility to execute its ...

    Benzinga
Dividend data last updated 06/07/2025 22:17:44 UTC